Fenofit Capsule contains Fenofibrate 200mg, a lipid-modifying agent primarily used to manage hyperlipidemia and hypertriglyceridemia. Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), which plays a crucial role in regulating lipid metabolism. This activation leads to increased oxidation of fatty acids, reduced triglyceride levels, and elevated high-density lipoprotein (HDL) cholesterol, thereby improving the overall lipid profile. Fenofit Capsule is indicated for patients with elevated cholesterol and triglyceride levels who are at risk of cardiovascular disease, particularly when diet and lifestyle modifications alone are insufficient. It is often prescribed alongside dietary changes, exercise, and weight control to maximize therapeutic benefits. The medication is generally well-tolerated, but patients should be monitored for potential side effects such as gastrointestinal disturbances, elevated liver enzymes, and muscle-related symptoms. Fenofit should be used cautiously in individuals with pre-existing liver or kidney conditions and is contraindicated in patients with severe hepatic impairment or gallbladder disease. Regular lipid profile assessments and liver function tests are recommended during treatment. Fenofit Capsule offers an effective option for managing dyslipidemia, helping to reduce the risk of atherosclerosis and related cardiovascular complications.